Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Mouse Anti-Human CD20-PE/CY7 (B-Ly1)

Cat. No.:
9350-17
PE/CY7 Anti-Human CD20 antibody for use in flow cytometry assays.
$286.00
Size Price (USD) Quantity
100 tests $286.00
More Information
Clone B-Ly1
Isotype Mouse IgG1κ
Isotype Control Mouse IgG1-PE/CY7 (15H6)
Specificity Human CD20
Alternative Names Leu-16, B1, Bp35, MS4A1, S7
Description CD20 is a 33-37 kDa unglycosylated phosphoprotein. Although not a member of the tetraspanin superfamily of cell surface receptors, it crosses the cell membrane four times. It is expressed on all stages of B cell differentiation except plasma cells. The CD20 molecule is involved in regulation of B cell differentiation presumably via its reported function as a Ca++ channel subunit.
Conjugate PE/CY7 (R-phycoerythrin/Cyanine 7)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide and a stabilizer
Clonality Monoclonal
Concentration Lot specific
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light; Do not freeze
Trademark Information Cy® is a registered trademark of Global Life Sciences Solutions Germany GmbH
Applications Flow Cytometry – Quality tested 5,6,8,9
Immunohistochemistry-Frozen Sections – Reported in literature 1,2
Immunohistochemistry-Paraffin Sections – Reported in literature 3
Immunoprecipitation – Reported in literature 4
Blocking – Reported in literature 5
Separation – Reported in literature 6
Cytoxicity – Reported in literature 7

RRID Number AB_2796766
Gene ID 931 (Human)
Gene ID Symbol MS4A1 (Human)
Gene ID Aliases B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16
UniProt ID P11836 (Human)
UniProt Name CD20_HUMAN (Human)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Kang YM, Zhang X, Wagner UG, Yang H, Beckenbaugh RD, Kurtin PJ, et al. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med. 2002;195:1325-36. (IHC-FS)
  2. 2. Yoon S, Zhang X, Lee IY, Spencer N, Vo P, Choi YS. CD9 is a novel marker for plasma cell precursors in human germinal centers. Biochem Biophys Res Commun. 2013;431:41-6. (IHC-FS)
  3. 3. Yang M, Xu Z, Zhuang Z. Macrophages affect immune inflammation and proliferation in benign prostatic hyperplasia via androgen receptor and CD40/CD40L signaling pathway. Tissue Cell. 2020;64:101343. (IHC-PS)
  4. 4. Dörken B, Möller P, Pezzutto A, Schwartz-Albiez R, Moldenhauer G. B-cell antigens: CD20. In: Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, et al, editors. Leukocyte Typing IV: White Cell Differentiation Antigens. Oxford: Oxford University Press; 1989. p. 46-48. (IP)
  5. 5. Tedder TF, Penta A. Structure of the CD20 antigen and gene of human and mouse B-cells: use of transfected cell lines to examine the workshop panel of antibodies. In: Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, et al, editors. Leukocyte Typing IV: White Cell Differentiation Antigens. Oxford: Oxford University Press; 1989. p. 48-50. (FC, Block)
  6. 6. Pawelec G, Müller R, Rehbein A, Hähnel K, Ziegler BL. Extrathymic T cell differentiation in vitro from human CD34+ stem cells. J Leukoc Biol. 1998;64:733-9. (FC, Sep)
  7. 7. Mössner E, Brünker P, Moser S, Püntener U, Schmidt C, Herter S, et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. Blood. 2010;115:4393-402. (Cyto)
  8. 8. Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol. 2000;165:5970-9. (FC)
  9. 9. Odendahl M, Keitzer R, Wahn U, Hiepe F, Radbruch A, Dörner T, et al. Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus. Ann Rheum Dis. 2003;62:851-8. (FC)
See All References